Peer Review Process
The Journal of Stem Cell Therapy and Transplantation (JSCTT) follows a rigorous peer review process to ensure the publication of high-quality, evidence-based research in stem cell therapy, regenerative medicine, and transplantation science. The journal upholds the highest standards of scientific integrity, ethical compliance, and research transparency.
Peer Review Process
1. Initial Manuscript Screening
Upon submission, each manuscript undergoes an initial review by the editorial team to determine if it meets the scope and quality standards of the journal. The evaluation includes:
- Relevance to stem cell research, regenerative medicine, and transplantation.
- Compliance with ethical guidelines, including IRB approval and informed consent for clinical studies.
- Adherence to journal formatting and reporting standards.
- Scientific soundness and originality of the study.
Manuscripts that do not meet these fundamental criteria may be rejected at this stage without external peer review.
2. Selection of Reviewers
Manuscripts passing the initial screening are assigned to expert reviewers specializing in stem cell biology, regenerative medicine, gene therapy, or transplantation sciences. Reviewers are chosen based on their academic credentials, research expertise, and prior contributions to the field.
3. Double-Blind Peer Review
The JSCTT follows a double-blind review process, ensuring that both authors and reviewers remain anonymous to maintain fairness, objectivity, and eliminate bias.
4. Reviewer Assessment
Reviewers evaluate manuscripts based on the following key criteria:
- Scientific Rigor: The study must be based on a robust methodology, well-defined experimental design, and appropriate statistical analysis.
- Clinical and Translational Relevance: The research should contribute to advancements in stem cell therapy, transplantation, or regenerative medicine.
- Novelty and Impact: The findings should introduce new insights, technologies, or treatment strategies.
- Clarity and Structure: The manuscript should be well-organized, clearly written, and logically structured.
- Ethical Compliance: The research must adhere to international ethical guidelines, including the use of human and animal subjects, genetic modifications, and patient confidentiality.
5. Editorial Decision
Based on the reviewers’ feedback, the editorial team makes one of the following decisions:
- Accept: The manuscript is approved for publication without further modifications.
- Minor Revisions: The manuscript requires minor changes before final acceptance.
- Major Revisions: The manuscript requires substantial modifications and may undergo a second round of peer review.
- Reject: The manuscript does not meet the journal’s quality or relevance criteria.
6. Revision and Resubmission
For manuscripts requiring revisions, authors must submit a revised version along with a detailed response document addressing the reviewers’ comments. The revised manuscript may be reassessed by the original reviewers before final acceptance.
7. Final Acceptance and Publication
Once the manuscript meets all necessary revisions and quality standards, it is accepted for publication. The final version undergoes editing, formatting, and proofreading before being published online and in print.
8. Post-Publication Review
The JSCTT encourages continued academic discussion and welcomes post-publication feedback. If readers or researchers identify any concerns related to accuracy, ethics, or methodology in a published article, appropriate corrections, clarifications, or retractions may be issued.
9. Ethical Compliance
The journal adheres to the ethical guidelines of the Committee on Publication Ethics (COPE) and follows best practices for research involving human subjects, animal models, and genetic engineering. Any suspected cases of research misconduct, data falsification, or conflicts of interest will be thoroughly investigated.
The JSCTT is committed to a fair, transparent, and timely peer review process. For any inquiries regarding the review process, please contact the editorial office.